Martin Weger
Department of Ophthalmology
Karl-Franzens University
Austria
Name/email consistency: high
- Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion. Weger, M., Renner, W., Pinter, O., Stanger, O., Temmel, W., Fellner, P., Schmut, O., Haas, A. Eye. (Lond) (2003)
- Chlamydia pneumoniae seropositivity and the risk of nonarteritic ischemic optic neuropathy. Weger, M., Haas, A., Stanger, O., El-Shabrawi, Y., Temmel, W., Maier, R., Berghold, A., Haller-Schober, E.M. Ophthalmology (2002)
- Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Weger, M., Stanger, O., Deutschmann, H., Temmel, W., Renner, W., Schmut, O., Semmelrock, J., Haas, A. Graefes Arch. Clin. Exp. Ophthalmol. (2002)
- Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Weger, M., Stanger, O., Deutschmann, H., Temmel, W., Renner, W., Schmut, O., Quehenberger, F., Semmelrock, J., Haas, A. Ophthalmology (2002)
- The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion. Weger, M., Stanger, O., Deutschmann, H., Leitner, F.J., Renner, W., Schmut, O., Semmelrock, J., Haas, A. Am. J. Ophthalmol. (2002)
- Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy. Weger, M., Stanger, O., Deutschmann, H., Simon, M., Renner, W., Schmut, O., Semmelrock, J., Haas, A. Br. J. Ophthalmol (2001)
- Role of factor XIII Val34Leu polymorphism in retinal artery occlusion. Weger, M., Renner, W., Stanger, O., Schmut, O., Deutschmann, H., Wascher, T.C., Haas, A. Stroke (2001)
